2 November 2020
Accrol Group Holdings plc
("Accrol" or the "Group")
COVID-19 BUSINESS UPDATE
Following the Government's announcement over the weekend that a second lockdown is being initiated from 5 November 2020, Accrol (AIM: ACRL) confirms that, as an essential service provider, it expects to operate normally throughout the lockdown period.
During the first nationwide lockdown in the Spring, Accrol operated at full capacity to supply the heightened consumer demand for its toilet roll and other tissue products and remained fully operational across its three sites, successfully protecting the health and safety of its employees throughout and subsequently through the period of regional restrictions.
The business prepared for a second national lockdown and heightened restrictions and is ready to satisfy additional demand, should it materialise.
For further information, please contact: |
|
|
|
Accrol Group Holdings plc |
|
Dan Wright, Executive Chairman |
Via Belvedere Communications |
Gareth Jenkins, Chief Executive Officer |
|
|
|
Zeus Capital Limited (Nominated Adviser & Broker) |
|
Dan Bate / Jordan Warburton |
Tel: +44 (0) 161 831 1512 |
Dominic King / John Goold |
Tel: +44 (0) 203 829 5000 |
|
|
Liberum Capital Limited (Joint Broker) |
Tel: +44 (0) 20 3100 2222 |
Clayton Bush / Edward Thomas |
|
|
|
Belvedere Communications Limited |
|
Cat Valentine |
Tel: +44 (0) 7715 769 078 |
Keeley Clarke |
Tel: +44 (0) 7967 816 525 |
|
accrolpr@belvederepr.com |
Notes to Editors
Accrol Group Holdings plc, based in Lancashire, is a leading tissue converter and supplier of toilet tissues, kitchen rolls and facial tissues, as well as other tissue products, to major discounters and grocery retailers throughout the UK. The business operates from four sites in Lancashire:
· |
A manufacturing, storage, and distribution facility in Blackburn; |
· |
A storage and administrative centre in Blackburn; |
· |
A facial tissue plant, also in Blackburn; and |
· |
A manufacturing, storage, and distribution facility in Leyland. |
For more information, please visit www.accrol.co.uk .